428 related articles for article (PubMed ID: 17064406)
21. Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracranial primitive neuroectodermal tumors.
Chang Q; Pang JC; Li KK; Poon WS; Zhou L; Ng HK
Hum Pathol; 2005 Dec; 36(12):1265-72. PubMed ID: 16311119
[TBL] [Abstract][Full Text] [Related]
22. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.
Harada K; Toyooka S; Maitra A; Maruyama R; Toyooka KO; Timmons CF; Tomlinson GE; Mastrangelo D; Hay RJ; Minna JD; Gazdar AF
Oncogene; 2002 Jun; 21(27):4345-9. PubMed ID: 12082624
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
Dammann R; Yang G; Pfeifer GP
Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494
[TBL] [Abstract][Full Text] [Related]
25. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation of the RASSF1A gene in gliomas.
Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y
Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871
[TBL] [Abstract][Full Text] [Related]
27. Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.
Murray PG; Qiu GH; Fu L; Waites ER; Srivastava G; Heys D; Agathanggelou A; Latif F; Grundy RG; Mann JR; Starczynski J; Crocker J; Parkes SE; Ambinder RF; Young LS; Tao Q
Oncogene; 2004 Feb; 23(6):1326-31. PubMed ID: 14961078
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
[TBL] [Abstract][Full Text] [Related]
29. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
30. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Höög A; Clark GJ; Ekström TJ; Bäckdahl M; Farnebo F; Larsson C
Endocr Relat Cancer; 2007 Mar; 14(1):125-34. PubMed ID: 17395981
[TBL] [Abstract][Full Text] [Related]
31. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.
Choy KW; Lee TC; Cheung KF; Fan DS; Lo KW; Beaverson KL; Abramson DH; Lam DS; Yu CB; Pang CP
Neoplasia; 2005 Mar; 7(3):200-6. PubMed ID: 15799820
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of suppressive role of RASSF1A gene at 3p21.3 in lung cancer cell line A549].
Zhang S; Shao K; Zhang CY; Zhou F; Wang W; Xiong MH; He J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):908-11. PubMed ID: 16029530
[TBL] [Abstract][Full Text] [Related]
34. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
[TBL] [Abstract][Full Text] [Related]
35. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours.
Pizzi S; Azzoni C; Bottarelli L; Campanini N; D'Adda T; Pasquali C; Rossi G; Rindi G; Bordi C
J Pathol; 2005 Aug; 206(4):409-16. PubMed ID: 15887288
[TBL] [Abstract][Full Text] [Related]
36. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
Liu L; Yoon JH; Dammann R; Pfeifer GP
Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
39. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma.
Macheiner D; Heller G; Kappel S; Bichler C; Stättner S; Ziegler B; Kandioler D; Wrba F; Schulte-Hermann R; Zöchbauer-Müller S; Grasl-Kraupp B
J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329
[TBL] [Abstract][Full Text] [Related]
40. Combined BubR1 protein down-regulation and RASSF1A hypermethylation in Wilms tumors with diverse cytogenetic changes.
Haruta M; Matsumoto Y; Izumi H; Watanabe N; Fukuzawa M; Matsuura S; Kaneko Y
Mol Carcinog; 2008 Sep; 47(9):660-6. PubMed ID: 18286482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
